Alkaptonuria: An autosomal recessive trait with altered metabolism of homogentisic acid. Affected individuals do not produce the enzyme to metabolize this acid.
Amino acid: One of the 20 subunits of proteins. Each contains an amino group, a carboxyl group, and an R group.
Codon: Triplets of nucleotides in mRNA that encode information for a specific amino acid in a protein.
Stop codon: A codon in mRNA that signals the end of translation. UAA, UAG, and UGA are stopcodons.
Start codon: A codon present in mRNA that signals the location for translation to begin. The codon AUG functions as a start codon and codes for the amino acid methionine.
pre-messenger RNA (pre-mRNA): The transcript made from the DNA template that is processed and modified to form messenger RNA.
Transcription: Transfer of genetic information from the base sequence of DNA to the base sequence of RNA brought about by RNA synthesis.
Messenger RNA (mRNA): A single-stranded complementary copy of the nucleotide sequence in a gene.
Translation: Conversion of information encoded in the nucleotide sequence on an mRNA molecule into the linear sequence of amino acids in a protein.
Promoter: A regulatory region located at the beginning of a gene.
Introns: DNA sequences present in some genes that are transcribed but are removed during processing and therefore are not present in mature mRNA.
Exons: DNA sequences that are transcribed, joined to other exons during mRNA processing, and translated into the amino acid sequence of a protein.
Cap: A modified base (guanine nucleotide) that is attached to the 5′ end of eukaryotic mRNA molecules.
Poly-A tail: A series of A nucleotides added to the 3′ end of mRNA molecules.
R group: Each amino acid has a different side chain, called an R group. An R group can be positively or negatively charged or neutral.
Amino group: A chemical group (NH2) found in amino acids and at one end of a polypeptide chain.
Carboxyl group: A chemical group (COOH) found in amino acids and at one end of a polypeptide chain.
Essential amino acids: Those amino acids that cannot be synthesized by the body and must be included in the diet.
Polypeptide: A molecule made of amino acids joined together by peptide bonds.
N-terminus: The end of a polypeptide or protein that has a free amino group.
C-terminus: The end of a polypeptide or protein that has a free carboxyl group.
Ribosomes: Cytoplasmic particles that aid in the production of proteins.
Ribosomal RNA (rRNA): RNA molecules that form part of the ribosome.
Transfer RNA (tRNA): A small RNA molecule that contains a binding site for a specific type of amino acid and a three-base segment known as an anticodon that recognizes a specific base sequence in messenger RNA.
Anticodon: A group of 3 nucleotides in a tRNA molecule that pairs with a complementary sequence (known as a codon) in an mRNA molecule.
Initiation complex: Formed by the combination of mRNA, tRNA, and the small ribosome subunit. The first step in translation.
Peptide bond: A covalent chemical link between the carboxyl group of one amino acid and the amino group of another amino acid.
Polysomes: A messenger RNA (mRNA) molecule with several ribosomes attached.
Chaperone: A protein that guides the folding of a polypeptide into a functional, three-dimensional shape, converting the polypeptide into a protein.
Proteome: The set of proteins present in a particular cell at a specific time under a particular set of conditions.
Primary structure: The amino acid sequence in a polypeptide chain.
Secondary structure: The pleated or helical structure in a protein molecule generated by the formation of bonds between amino acids.
Tertiary structure: The three dimensional structure of a protein molecule brought about by folding on itself.
Quaternary structure: The structure formed by the interaction of two or more polypeptide chains in a protein.
Prion: A protein folded into an infectious conformation that is the cause of several disorders, including Creutzfeldt-Jakob disease and mad-cow disease.
Mad-cow disease: A prion disease of cattle, also known as bovine spongiform encephalopathy, or BSE.
Chromatin remodeling: The set of chemical changes to the DNA and histones that activate and inactivate gene expression.
RNA interference (RNAi): A mechanism of gene regulation that controls the amounts of mRNA available for translation.
Substrate: The specific chemical compound that is acted on by an enzyme.
Product: The specific chemical compound that is the result of enzymatic action. In biochemical pathways, a compound can serve as the product of one reaction and the substrate for the next reaction.
Metabolism: The sum of all biochemical reactions by which cells convert and utilize energy.
Inborn error of metabolism: The concept advanced by Archibald Garrod that many genetic traits result from alterations in biochemical pathways.
Essential amino acids: Amino acids that cannot be synthesized in the body and must be supplied in the diet.
Phenylketonuria (PKU): An autosomal recessive disorder of amino acid metabolism that results in intellectual disability if untreated.
Galactosemia: A heritable trait associated with the inability to metabolize the sugar galactose. If it is left untreated, high levels of galactose-1-phosphate accumulate, causing cataracts and intellectual disability.
Hemoglobin variants: Alpha and beta globins with variant amino acid sequences.
Thalassemias: Disorders associated with an imbalance in the production of alpha and beta globin.
Pharmacogenetics: A branch of genetics concerned with the identification of protein variants that underlie differences in the response to drugs.
Ecogenetics: A branch of genetics that studies genetic traits related to the response to environmental substances.
Mutation rate: The number of events that produce mutated alleles per locus per generation.
Trinucleotide repeats: A form of mutation associated with the expansion in copy number of a nucleotide triplet in or near a gene.
Mutagens: Physical or chemical agents that cause mutations.
Tautomeric shift: A reversible structural change in a molecule brought about by a shift in the location of a hydrogen atom.
Radiation: The process by which electromagnetic energy travels through space or a medium such as air.
Background radiation: Radiation in the environment that contributes to radiation exposure.
Rem: The unit of radiation exposure used to measure radiation damage in humans. It is the amount of ionizing radiation that has the same effect as a standard dose of x-rays.
Millirem: A rem is a measure of radiation dose equal to 1000 millirems.
Base analogs: A purine or pyrimidine that differs in chemical structure from those normally found in DNA and RNA.
Nucleotide substitutions: Mutations that involve replacement of one or more nucleotides in a DNA molecule with other nucleotides.
Frameshift mutations: Mutational events in which a number of bases (other than multiples of three) are added to or removed from DNA, causing a shift in the codon reading frame.
Missense mutations: Mutations that cause the substitution of one amino acid for another in a protein.
Sense mutations: Mutations that change a termination codon into one that codes for an amino acid. Such mutations produce elongated proteins.
Nonsense mutations: Mutations that change an amino acid specifying a codon to one of the three termination codons.
Allelic expansion: Increase in gene size caused by an increase in the number of trinucleotide repeat sequences.
Epigenetics: The study of chemical modifications of chromosomal DNA (such as methylation of bases) and/or associated histone proteins that change the pattern of gene expression without affecting the nucleotide sequence of the DNA.
Epigentic trait: Phenotype that is produced by epigenetic changes to DNA.
Epigenome: The epigenetic state of a cell.
Promoter: Regulatory region located at the beginning of a gene.
Methylation: Addition of a methyl group to a DNA base or a protein.
Genetic imprinting: Selective expression of either the maternal or paternal copy of a gene.